Evidence map›Paper›PMID 18948086›Full record

ArticleBiochemical pharmacology2009

Catalase and glutathione peroxidase mimics.

Brian J Day

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Stage-Specific Proteomic Adaptations to Heme-Induced Oxidative Stress inInternational journal of molecular sciences · 2026
    Article
  5. Lemongrass (Biochemistry research international · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Unlocking the potential ofFrontiers in microbiology · 2024
    Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Brian J DayDepartment of Medicine, National Jewish Health, Departments of Medicine, Immunology & Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, CO 80206, USA. dayb@njc.org.
National Jewish Health · US

Funding

Thiols in sulfur mustard toxicityU54ES015678 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI WHITE, CARL W · 2006 to 2015
$20.5M
Targeting Oxidative Stress in Chronic Beryllium DiseaseR01ES017582 · NIEHS · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J, MAIER, LISA A · 2009 to 2013
$1.7M
Adaptive glutathione responses to cigarette smoke in COPDR01HL084469 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2008 to 2011
$1.6M
Glutathione transport, oxidative stress and lung injuryR01HL075523 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2004 to 2007
$1.3M
Role of Oxidatve Stress in Chronic Beryllium DiseaseR01ES012504 · NIEHS · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2003 to 2006
$1.1M
NHLBI NIH HHS HL075523NHLBI NIH HHS HL084469NHLBI NIH HHS R01 HL075523NHLBI NIH HHS R01 HL084469NIEHS NIH HHS ES012504NIEHS NIH HHS ES015678NIEHS NIH HHS R01 ES012504NIEHS NIH HHS R01 ES017582NIEHS NIH HHS U54 ES015678
6 · The paper itself

Abstract

Overproduction of the reactive oxygen species (ROS) superoxide (O(2)(-)) and hydrogen peroxide (H(2)O(2)) are increasingly implicated in human disease and aging. ROS are also being explored as important modulating agents in a number of cell signaling pathways. Earlier work has focused on development of small catalytic scavengers of O(2)(-), commonly referred to as superoxide dismutase (SOD) mimetics. Many of these compounds also have substantial abilities to catalytically scavenge H(2)O(2) and peroxynitrite (ONOO(-)). Peroxides have been increasingly shown to disrupt cell signaling cascades associated with excessive inflammation associated with a wide variety of human diseases. Early studies with enzymatic scavengers like SOD frequently reported little or no beneficial effect in biologic models unless SOD was combined with catalase or a peroxidase. Increasing attention has been devoted to developing catalase or peroxidase mimetics as a way to treat overt inflammation associated with the pathophysiology of many human disorders. This review will focus on recent development of catalytic scavengers of peroxides and their potential use as therapeutic agents for pulmonary, cardiovascular, neurodegenerative and inflammatory disorders.

Indexed as

Molecular MimicryAnimalsAntioxidantsBiocatalysisCatalaseFree Radical ScavengersGlutathione PeroxidaseHumansHydrogen PeroxideReactive Oxygen SpeciesAntioxidantsCatalaseFree Radical ScavengersGlutathione PeroxidaseHydrogen PeroxideReactive Oxygen Species

Identifiers

PMID18948086
PMCPMC2657365
OpenAlexW2112906433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.